v3.24.0.1
Stockholders’ Equity - Narrative (Details)
$ / shares in Units, $ in Thousands
 1 Months Ended 3 Months Ended 12 Months Ended
Mar. 02, 2023
provider
$ / shares
shares
Apr. 06, 2021
USD ($)
shares
Apr. 01, 2021
Apr. 30, 2021
shares
Jun. 30, 2022
USD ($)
Dec. 31, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2021
USD ($)
shares
Aug. 31, 2023
provider
Aug. 28, 2018
shares
Aug. 27, 2018
shares
Jan. 17, 2014
shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Common stock, par value (in dollars per share) | $ / shares $ 0.01         $ 0.01 $ 0.01          
Number of providers | provider                 50      
Common stock, shares authorized (in shares)           1,000,000,000 1,000,000,000          
Number of options granted           0 93,793 3,753,317        
Unrecognized share-based compensation expense | $           $ 79,400            
Period for recognition           1 year 2 months 12 days            
Common stock, shares issued (in shares)           118,216,979 114,690,808          
Share based payment expense | $           $ 37,098 $ 67,359 $ 253,531        
Share based payment expense, tax benefit | $           2,400 $ 11,200          
Fair value of shares vested | $           74,700            
Intrinsic value of options exercised | $           $ 14,600            
Equity Alignment Agreement | Novant Health, Inc                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Equity alignment agreement will renew period 4 years                      
Award percentage of total common stock issued and outstanding (up to) 19.90%                      
Agreement Condition One | Equity Alignment Agreement | Novant Health, Inc                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Number of shares issued in transaction 745,712                      
Agreement Condition One | Affiliated Entity | Equity Alignment Agreement | Privia Medical Group Tennessee, PLLC                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Number of providers | provider 1,000                      
Agreement Condition Two | Equity Alignment Agreement | Novant Health, Inc                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Number of shares issued in transaction 372,856                      
Agreement Condition Three | Equity Alignment Agreement | Novant Health, Inc                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Number of shares issued in transaction 745,712                      
Agreement Condition Three | Affiliated Entity | Equity Alignment Agreement | Privia Medical Group Tennessee, PLLC                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Number of providers | provider 1,000                      
2021 Omnibus Incentive Plan                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Common stock, shares authorized (in shares)   10,278,581                    
Award percentage increase   5.00%                    
Options grant price percent of fair market value of company stock price (at least)   100.00%                    
Number of options granted   3,683,217                    
Unrecognized share-based compensation expense | $   $ 62,300                    
Period for recognition   4 years                    
2021 ESPP                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Number of shares authorized       10,278,581                
Award percentage of total common stock issued and outstanding (up to)       1.00%                
Common stock, shares issued (in shares)       1,027,858   0 0          
Chief Executive Officer                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Accelerated vesting, percent     100.00%                  
At IPO                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Accelerated vesting, percent     60.00%                  
12months after IPO                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Accelerated vesting, percent     20.00%                  
Accelerated vesting, period     12 months                  
18 months after IPO                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Accelerated vesting, percent     20.00%                  
Accelerated vesting, period     18 months                  
Options                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Number of shares authorized                   18,985,846 4,229,850 4,229,850
Period of acceleration     1 year                  
Accelerated cost | $         $ 195,100              
Options | Chief Executive Officer                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Period of acceleration     4 months                  
Restricted Stock Units (RSUs)                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Number of instruments granted           1,161,301 1,679,107 1,199,315        
Restricted Stock Units (RSUs) | 2021 Omnibus Incentive Plan                        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                        
Number of instruments granted   1,183,871